Small Molecules
26 October 2019
LIPAC Oncology Announces Successful Completion of Phase 1 Bladder Cancer Clinical Study and Initiation of Phase 2A Study23 October 2019
Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC Targeted Protein Degraders23 October 2019
Oligomerix Presents Preclinical Data on Lead Alzheimer’s Disease Candidate at Neuroscience 201921 October 2019
Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-296521 October 2019
Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes19 October 2019
Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers18 October 2019
Syros Announces Update on Selective CDK7 Inhibitor Portfolio18 October 2019
Plexium Launches with $28 Million in Series A FinancingNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports